ConductScience.org, home

Paper20145007

Low-valency, but not monovalent, antigens trigger the B-cell antigen receptor (BCR).

Minguet S and 2 others. Int Immunol, 2010. Cited by 54 papers, by iCite.

Cite this record

ConductScience Library. Low-valency, but not monovalent, antigens trigger the B-cell antigen receptor (BCR). Papers, record 20145007. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20145007

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Low-valency, but not monovalent, antigens trigger the B-cell antigen receptor (BCR).
PubMed
Journal
Int Immunol
PubMed
Year
2010
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
54
iCite
Relative citation ratio, by iCite
1.03
iCite
Revised in PubMed
2010-02-26
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Minguet SSusana
2Dopfer EPElaine-Pashupati
3Schamel WWWolfgang W A

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AntigensMajor topic
Lymphocyte ActivationMajor topic
Receptors, Antigen, B-CellMajor topic
Animals
Antibodies, Anti-Idiotypic
B-Lymphocytes
Blotting, Western
Gene Knock-In Techniques
Haptens
Mice
Mice, Knockout

Source PubMed

Download CSV of topics

Cited by40

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.

PMIDTitleJournalYearIn PapersSource
40916640New insights to B cell tolerance involving the mechanosensitive ion channel Piezo1.BMB Rep2026https://conductscience.org/library/papers/40916640PubMed
40770085Immunoglobulin divalence promotes B-cell antigen receptor cluster scale-dependent functions.Cell Mol Immunol2025https://conductscience.org/library/papers/40770085PubMed
40354540Antigen mobility regulates the dynamics and precision of antigen capture in the B cell immune synapse.Proc Natl Acad Sci U S A2025https://conductscience.org/library/papers/40354540PubMed
39948415Dynamics and activation of membrane-bound B cell receptor assembly.Commun Biol2025https://conductscience.org/library/papers/39948415PubMed
39462119Engineered protein subunit COVID19 vaccine is as immunogenic as nanoparticles in mouse and hamster models.Sci Rep2024https://conductscience.org/library/papers/39462119PubMed
39413488Chikungunya virus E2 B domain nanoparticle immunogen elicits homotypic neutralizing antibody in mice.Vaccine2024https://conductscience.org/library/papers/39413488PubMed
39256626Towards a unifying model for B-cell receptor triggering.Nat Rev Immunol2025https://conductscience.org/library/papers/39256626PubMed
39185403Both sides now: evolutionary traits of antigens and B cells in tolerance and activation.Front Immunol2024https://conductscience.org/library/papers/39185403PubMed
38794795Mechanical control of antigen detection and discrimination by T and B cell receptors.Biophys J2024https://conductscience.org/library/papers/38794795PubMed
37862070Effect of Antigen Valency on Autoreactive B-Cell Targeting.Mol Pharm2024https://conductscience.org/library/papers/37862070PubMed
37840242Extracellular matrix rigidity modulates physical properties of subcapsular sinus macrophage-B cell immune synapses.Biophys J2024https://conductscience.org/library/papers/37840242PubMed
37088158DNA-scaffolded multivalent vaccine against SARS-CoV-2.Acta Biomater2023https://conductscience.org/library/papers/37088158PubMed
36813795Antigen footprint governs activation of the B cell receptor.Nat Commun2023https://conductscience.org/library/papers/36813795PubMed
36275764Comparative analysis of the repertoire of insulin-reactive B cells in type 1 diabetes-prone and resistant mice.Front Immunol2022https://conductscience.org/library/papers/36275764PubMed
35023430Mechanisms of cellular and humoral immunity through the lens of VLP-based vaccines.Expert Rev Vaccines2022https://conductscience.org/library/papers/35023430PubMed
33875654A Chlamydia trachomatis VD1-MOMP vaccine elicits cross-neutralizing and protective antibodies against C/C-related complex serovars.NPJ Vaccines2021https://conductscience.org/library/papers/33875654PubMed
33801906Immunogenicity of HIV-1-Based Virus-Like Particles with Increased Incorporation and Stability of Membrane-Bound Env.Vaccines (Basel)2021https://conductscience.org/library/papers/33801906PubMed
32601450Role of nanoscale antigen organization on B-cell activation probed using DNA origami.Nat Nanotechnol2020https://conductscience.org/library/papers/32601450PubMed
32483855Factors in B cell competition and immunodominance.Immunol Rev2020https://conductscience.org/library/papers/32483855PubMed
31877064Synergistic factors control kinase-phosphatase organization in B-cells engaged with supported bilayers.Mol Biol Cell2020https://conductscience.org/library/papers/31877064PubMed

See all 40 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20145007

GET https://conductscience.org/api/papers/v1/20145007/cited_by?page=2